HON + QNT: Trading Cheat Sheet

• HON (Honeywell International) — NYSE
• 52-week range: $186.76 to $248.18
• All-time closing high: $246.68 (March 2, 2026)
• Daily technical signal: Strong Buy
• Beta: 0.84 (lower volatility vs. pure-play quantum names)
• Goldman Sachs price target: $276 (raised from $258)
• Analyst consensus target: $247.22 | High: $292 | Low: $198
• FY2025 adjusted EPS guidance: $10.60–$10.70
• QNT (Quantinuum) — Nasdaq
• IPO date: June 3, 2026
• IPO price: $60 per share
• Capital raised: $1.68 billion
• Post-IPO valuation: $15.6 billion
• 2025 annual revenue: $30.9 million
• Key risk: RIKEN (single client) = 90% of 2025 revenue
• Commercial systems operating: 4 globally, 5th expected Singapore late 2026

Honeywell (HON): The Quantum Spin That Wall Street Is Watching

Most people weren’t paying attention. Then June 3rd happened.

Quantinuum priced at $60 a share, pulled $1.68 billion out of the market, and came out the other side with a $15.6 billion post-IPO valuation. Ticker QNT. Now it’s public. And the question isn’t whether this was a big deal. It clearly was. The question is what it actually means for HON shareholders who’ve been holding a defense-and-automation conglomerate and now suddenly have indirect exposure to one of the most speculative verticals in tech.

Start with what Honeywell actually is, because it’s easy to lose the thread here.

This is a 100-plus-year-old Charlotte, North Carolina industrial business. Roughly 101,000 employees. Deep aerospace contracts, building automation, industrial process technology woven into global infrastructure at a level most people don’t think about. The same company that just brought a quantum unit public also makes aircraft components and factory sensors. That’s not a contradiction, it’s just what large conglomerates look like. What matters right now is that Honeywell is actively dismantling itself into three separate public companies. Solstice Advanced Materials spun out October 30, 2025. Full separations of Automation and Aerospace Technologies are still working through the process. Quantinuum was the loudest piece of the restructuring. But it’s one piece of a much larger break-up play.

Quantinuum came together in 2021 when Honeywell merged its internal quantum division with Cambridge Quantum, a U.K.-based software firm. The hardware is trapped-ion. The software stack includes development tools like TKET targeting chemistry simulation, cryptography, and optimization. Clients on the roster: Airbus, BMW Group, JPMorgan Chase, Amgen. Looks diversified. Here’s the thing though: RIKEN, a single Japanese research institute, accounted for 90% of 2025 revenue. One client. Nine zero percent. That’s the number that doesn’t make it into the lead paragraph of most IPO coverage, and it’s the one worth sitting with longest.

The technology itself is advancing. A collaboration with Microsoft’s quantum team produced four logical qubits with error rates 800 times lower than the corresponding physical error rates. Error correction is the ceiling this whole field keeps hitting. That result is a real crack in it, not a breakthrough, but progress you can point to. Four commercial systems are running globally right now. A fifth is coming to Singapore before year-end 2026.

Slight tangent, but it changes the math: the Trump administration committed $2 billion spread across nine quantum companies. That’s not just capital, it’s a policy signal, and policy signals at that scale tend to pull institutional money in behind them whether the underlying technology is ready or not.

The competitive landscape is worth being honest about.

IonQ is the most direct comparison and it’s not close on revenue. IonQ did roughly $130 million in 2025 sales with 2026 guidance of $225-245 million. QNT is at $30.9 million annually and losing money faster than it’s growing the top line. The other names in the public quantum space, IBM, Google, D-Wave (QBTS), Rigetti (RGTI), each bring different hardware architectures and different financial profiles. The broader market context: North America holds about 61% of the global quantum computing market, valued near $617.5 million in 2025, with projections pointing toward $8.5 billion by 2035 at a CAGR near 30%. That’s the long-horizon number underwriting every valuation in this space right now. QNT at $15.6 billion on $30.9 million in revenue is not a today trade. It’s a 2030-plus trade dressed up in a 2026 IPO.

Now the HON earnings picture, which is actually the cleaner story.

• Q1 2025: 8% sales growth, 4% organic, second straight quarter of double-digit organic growth in defense and space
• Q2 2025: 8% sales growth, 5% organic, double-digit defense and space again, adjusted EPS $2.75 up 10% YoY
• Q3 2025: 7% sales growth, 6% organic, EPS $2.86 up 32%, adjusted EPS $2.82 up 9%

Three quarters in a row with defense and space as the lead growth driver. Full-year 2025 guidance called for 6% revenue growth and adjusted EPS of $10.60-$10.70. The quantum unit is not what’s moving the earnings needle. Defense is. That disconnect between where the stock’s current attention is and where the actual earnings momentum lives is something worth filing away.

On the technical side, HON is sitting in a 52-week range of $186.76 to $248.18. The all-time closing high was $246.68 on March 2, 2026. It’s pulled back from there. Moving averages are registering a Strong Buy on the daily. Goldman lifted its target to $276 from $258. Consensus sits at $247.22 with a $292 high and $198 low from the analyst community. The 0.84 beta is what keeps coming back to mind. For anyone who wants exposure to quantum computing without the violent daily moves that come with IONQ or RGTI, HON is a structurally quieter way into the same theme.

What the QNT IPO did, more than anything, is create a public price on something that was previously invisible on a balance sheet. That’s genuinely new information. Whether the market priced it right at $15.6 billion is a different conversation entirely. One that’s going to play out over many quarters, not a few sessions.

The RIKEN dependency is still there. The losses are still widening. And the defense segment inside HON is still doing the actual work.

Keep watching how QNT trades once the IPO noise fades.

— The Editorial Desk